‹ ›
MYP_039563
← PREVIOUS NEXT → BACK
Basic Information
MERS-CoV-HR2P [T1263E,L1267R]
Anticancer ▸ Cytotoxic anticancer activity ▸ Cytotoxic
Antimicrobial
Antiviral
Antiviral ▸ Antiviral mechanism ▸ Viral fusion inhibition
Membrane / Ion-channel modulation ▸ Sodium channel modulation ▸ Sodium channel inhibitor
Toxicity / Safety ▸ Cytotoxicity ▸ Cytotoxic
Venom / Toxin ▸ General toxin ▸ Cytotoxic
Standard
36 amino acids
C186H308N46O62S
Standard
Sequence
SLTQINTTLLDLEYEMRSLQQVVKALNESYIDLKEL
Physicochemical Analysis
4212.77 Da
4.36
-3.53
-3.75
-0.0981
-0.18
0.78
0.00
27.79
127.22
0.0556
2980.00
2980.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1796.85
-15.59
61.0
60.0
147.0
295.0
2.0
40.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0172135 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral Cytotoxic
PMID24473083 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24473083/
RECORD: Rec_0175671 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
inhibition of MERS-CoV infection in Vero cells
0.6 μM
IC50
PMID24473083 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24473083/
RECORD: Rec_0192910 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
MERS-COV(Middle East respiratory syndrome coronavirus):inhibition of cell-cell fusion infection in Huh-7 and 293T/MERS/EGFP cells
0.93±0.15 μM
IC50
PMID24473083 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24473083/
RECORD: Rec_0219125 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
HR2 fusion-inhibitory peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-MERS-CoV Fusion inhibition
inhibition of MERS-CoV infection in Calu-3 cells
0.6 μM
IC50
Mammalian: 1.9 h; Yeast: >20 h; E. coli: >10 h
PaperStructure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. | Lu L, Liu Q, Zhu Y, Chan KH, Qin L, Li Y, Wang Q, Chan JF, Du L, Yu F, Ma C, Ye S, Yuen KY, Zhang R, Jiang S. | Nat Commun. 2014;5:3067. | DOI:10.1038/ncomms4067 | PMID:24473083 PMID24473083 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24473083/
RECORD: Rec_0308448 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
HR2 fusion-inhibitory peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-MERS-CoV Fusion inhibition
inhibition of MERS-CoV infection in Vero cells
0.6 μM
IC50
Mammalian: 1.9 h; Yeast: >20 h; E. coli: >10 h
PaperStructure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. | Lu L, Liu Q, Zhu Y, Chan KH, Qin L, Li Y, Wang Q, Chan JF, Du L, Yu F, Ma C, Ye S, Yuen KY, Zhang R, Jiang S. | Nat Commun. 2014;5:3067. | DOI:10.1038/ncomms4067 | PMID:24473083 PMID24473083 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24473083/
FIRST PREV 1 2 3 NEXT LAST
Showing 5 records on this page · Page 2 of 3